APA (7th ed.) Citation

Bennett, J. W., Yadava, A., Tosh, D., Sattabongkot, J., Komisar, J., Ware, L. A., . . . Birkett, A. (2016). Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy. PLoS Neglected Tropical Diseases, 10(2), 1. https://doi.org/10.1371/journal.pntd.0004423

Chicago Style (17th ed.) Citation

Bennett, Jason W., et al. "Phase 1/2a Trial of Plasmodium Vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy." PLoS Neglected Tropical Diseases 10, no. 2 (2016): 1. https://doi.org/10.1371/journal.pntd.0004423.

MLA (9th ed.) Citation

Bennett, Jason W., et al. "Phase 1/2a Trial of Plasmodium Vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy." PLoS Neglected Tropical Diseases, vol. 10, no. 2, 2016, p. 1, https://doi.org/10.1371/journal.pntd.0004423.